Michael Lidsky, MD

My Locations

Duke Cancer Center

20 Duke Medicine Cir

Durham, NC 27710

Get Directions

Duke Cancer Center Gastrointestinal (GI) Clinic

20 Duke Medicine Cir
Clinic 3-2

Durham, NC 27710-2000

Office: 919-668-6688 Get Directions

About Me

Learn More About Me

My clinical interest is in caring for patients with pre-cancerous and cancerous conditions of the liver, bile ducts, and pancreas. I enjoy treating each patient with a personalized and holistic therapeutic plan, oftentimes using creativity to tailor treatment specifically to them. Being a surgeon at Duke means that I can collaborate with experts from many different specialties and work with a team of caring, compassionate, and talented support staff to provide an unrivaled experience and the best outcomes for patients. Outside of the hospital, I enjoy spending time with my wife, two children, and dog, exploring the natural beauty of Durham and surrounding areas in North Carolina, and supporting local entrepreneurs by dining at local restaurants and attending events in the community, such as the Durham Farmers' Market.

School of Medicine Departments and Divisions

Surgery
- Surgical Oncology

Current Appointments and Affiliations

Associate Professor of Surgery, Surgical Oncology 2023
Member of the Duke Cancer Institute, Duke Cancer Institute 2018

Languages

English

Areas of Expertise

Cholangiocarcinoma
Hepatic Artery Infusion
Liver Surgery
Pancreatic Cancer
Pancreatic Surgery

Training

Board Certifications

American Board of Surgery, General Surgery

American Board of Surgery, Complex General Surgical Oncology

Residency

General Surgery, Duke University, 2009-2016

Education

MD, Georgetown University (Washington, D.C.), 2009

Fellowship

Surgical Oncology, Memorial Sloan Kettering Cancer Center (New York), 2016-2018

Hepato-pancreato-biliary Surgery, Memorial Sloan Kettering Cancer Center (New York), 2017-2018

Clinical Focus and Research

My Research Interests

I am dedicated to advancing cancer care and improving patient outcomes through research. My research explores genomic and molecular pathways of resistance to chemotherapy for hepatobiliary cancers. Specifically, we use a pre-clinical model for primary hepatic malignancies, such as intrahepatic cholangiocarcinoma, to recapitulate critical events in these tumors so that we can identify mechanisms driving tumor growth, metastasis, and resistance to chemotherapy. Ultimately, this model serves as a vehicle for the discovery of new or more efficacious therapies.

Publications and Grants

Merkow, Ryan P., Michael J. Cavnar, Ana L. Gleisner, Skye C. Mayo, Sepideh Gholami, Paul J. Karanicolas, Bas Groot Koerkamp, et al. “Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective.” Ann Surg Oncol 32, no. 6 (June 2025): 4408–16. https://doi.org/10.1245/s10434-025-17009-1.
Schleimer, Lauren E., Annie Liu, Hannah L. Kalvin, Ahmad Bashir Barekzai, Ankur P. Choubey, Joslyn Jung, Rubiya Haque, et al. “Robotic Versus Open Placement of Hepatic Artery Infusion Pumps.” Ann Surg Oncol 32, no. 5 (May 2025): 3488–98. https://doi.org/10.1245/s10434-025-16915-8.
Sharib, Jeremy, Kristen E. Rhodin, Annie Liu, Sarah McIntyre, Alex Bartholomew, Sabran Masoud, Isabel DeLaura, et al. “Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.” Ann Surg Oncol 32, no. 4 (April 2025): 2456–66. https://doi.org/10.1245/s10434-024-16799-0.

Sharib, J., B. Clary, and M. E. Lidsky. “Role of Neoadjuvant therapy in the treatment of patients with colorectal liver metastases.” In Contemporary Management of Metastatic Colorectal Cancer: A Precision Medicine Approach, 81–99, 2022. https://doi.org/10.1016/B978-0-323-91706-3.00013-8.
Lidsky, M. E., D. A. Bruno, and A. D. Kirk. “Chapter 111 - Liver and pancreas transplantation immunobiology.” In Blumgart’s Surgery of the Liver, Biliary Tract and Pancreas: Sixth Edition, 2–2:1726-1736.e3, 2017. https://doi.org/10.1016/B978-0-323-34062-5.00111-4.

Liu, Annie, Melissa Lowe, Donna Niedzwiecki, Kristen E. Rhodin, Jeremy Sharib, Benjamin Wildman-Tobriner, Terence Z. Wong, et al. “Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program.” In Ann Surg Oncol, 32:1033–42, 2025. https://doi.org/10.1245/s10434-024-16488-y.
Sharib, Jeremy, Annie Liu, Sarah McIntyre, Kristen E. Rhodin, Nancy E. Kemeny, Andrea Cercek, James J. Harding, et al. “Adjuvant Chemotherapy for Resected Intrahepatic Cholangiocarcinoma Confers No Survival Advantage.” In ANNALS OF SURGICAL ONCOLOGY, 30:S10–S10, 2023.
Eckhoff, Austin, Elishama Kanu, Berk Aykut, Matthew Bao, Dan G. I. I. I. Blazer, Sabino Zani, Michael E. Lidsky, Peter J. Allen, and Daniel P. Nussbaum. “Survival for Patients with Radiographically Occult Metastatic Pancreatic Adenocarcinoma in the Era of Modern Multiagent Chemotherapy.” In ANNALS OF SURGICAL ONCOLOGY, 30:S108–S108, 2023.

Ratings and Reviews

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Overall Provider Rating

4.87 out of 5

131 ratings, 9 reviews

Patient Reviews

Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy

Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna/CVS Health
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Value Plan (HMO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
Ambetter
- Ambetter of North Carolina
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
- *Duke HomeCare and Hospice does not participate in the plan.
CIGNA
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
- *Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
Duke Group Plans
- Duke Basic
- Duke Select
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
First Health
Gateway Health Alliance
Halifax Physician-Hospital Organization
- Halifax Physician-Hospital Organization plans*
- *This plan is only accepted at Duke University Hospital, Duke Regional Hospital, Duke Raleigh Hospital, and Duke HomeCare & Hospice.
Healthgram

Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
MedCost
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
MultiPlan / Private Healthcare Systems
NC Medicaid
- WellCare of North Carolina
- UnitedHealthcare Community Plan
- NC Medicaid Direct
- Healthy Blue
- Carolina Complete Health
- AmeriHealth Caritas North Carolina
OneNet PPO
Optima Health
- FAMIS*
- Optima Family Care (Medicaid HMO in VA)*
- Optima Individual & Family (On & Off Exchange Plans)
- Optima Plus (PPO)
- Optima Vantage (HMO)
- *Duke Primary Care, Duke University Hospital, Duke Regional Hospital, and Duke Raleigh Hospital are not participating with this plan.
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
- *Duke HomeCare and Hospice and mental health providers do not participate with the plan.

External Relationships

Duke requires faculty members to report certain relationships outside of their employment in order to ensure potential conflicts can be addressed. This faculty member has reported no outside activities that relate to their Duke responsibilities.